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IMPORTANCE Psychiatric traits associated with categorically defined psychiatric disorders are
heritable and present to varying degrees in the general population. It is commonly assumed
that diagnoses represent the extreme end of continuously distributed traits in the population,
but this assumption has yet to be robustly tested for many psychiatric phenotypes.
OBJECTIVE To assess whether genetic risk factors associated with psychiatric disorders are
also associated with continuous variation in milder population traits.
DESIGN, SETTING, AND PARTICIPANTS This study combined a novel twin analytic approach
with polygenic risk score (PRS) analyses in a large population-based twin sample. Phenotypic
and genetic data were available from the Child and Adolescent Twin Study in Sweden.
Inpatient data were available for January 1, 1987, to December 31, 2014, and outpatient data
for January 1, 2001, to December 31, 2013. The last day of follow-up was December 31, 2014.
Data analysis was performed from January 1, 2017, to September 30, 2017.
MAIN OUTCOMES ANDMEASURES Questionnaires that assessed traits of autism spectrum
disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), learning difficulties, tic
disorders (TDs), obsessive-compulsive disorder (OCD), anxiety, major depressive disorder
(MDD), mania, and psychotic experiences were administered to a large Swedish twin sample.
Individuals with clinical psychiatric diagnoses were identified using the Swedish National
Patient Register. Joint categorical/continuous twin modeling was used to estimate genetic
correlations between psychiatric diagnoses and continuous traits. The PRSs for psychiatric
disorders were calculated based on independent discovery genetic data. The association
between PRSs for each disorder and associated continuous traits was tested.
RESULTS Phenotype data were available for 13 923 twin pairs (35.1% opposite sex and 31.7%
same-sex females) at 9 years of age, 5165 pairs (36.9% opposite sex and 34.0% same-sex
females) at 15 years of age, and 4273 pairs (36.5% opposite sex and 34.4% same-sex females)
at 18 years of age. Genetic data were available for 13 412 individuals (50.2% females). Twin
genetic correlations between numerous psychiatric diagnoses and corresponding traits
ranged from0.31 to 0.69. Disorder PRSs were associated with related population traits for
ASD (β [SE] = 0.04 [0.01] at 9 years of age), ADHD (β [SE] = 0.27 [0.03] at 9 years of age),
TDs (β [SE] = 0.02 [0.004] at 9 years of age), OCD (β [SE] = 0.13 [0.05] at 18 years of age),
anxiety (β [SE] = 0.18 [0.08] at 9 years of age; β [SE] = 0.07 [0.02] at 15 years of age; and β
[SE] = 0.40 [0.17] at 18 years of age), MDD (β [SE] = 0.10 [0.03] at 9 years of age; β
[SE] = 0.11 [0.02] at 15 years of age; and β [SE] = 0.41 [0.10] at 18 years of age), and
schizophrenia (β [SE] = 0.02 [0.01] at 18 years of age). Polygenic risk scores for depressive
symptoms were associated with MDD diagnoses (odds ratio, 1.16; 95% CI, 1.02-1.32).
CONCLUSIONS AND RELEVANCE These results suggest that genetic factors associated with
psychiatric disorders are also associated with milder variation in characteristic traits
throughout the general population for many psychiatric phenotypes. This study suggests that
many psychiatric disorders are likely to be continuous phenotypes rather than the categorical
entities currently defined in diagnostic manuals, which has strong implications for genetic
research in particular.
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P sychiatric disorders are impairing and associated withgenetic factors.1 Although clinical practice and mostgenetic studies follow a case-control conceptualiza-
tion of these disorders, subclinical traits of these disorders
are common among unaffected individuals and are as heri-
table as the disorders themselves based on twin methods.2
One common theory is that the genetic risks for psychiatric
disorders are associated with these milder traits and that
psychiatric disorders arise after particularly strong exposure
to the same genetic risks associated with these traits.2
Preliminary support for this theory comes from twin
and molecular genetic studies. Twin studies indicate consis-
tent heritability of traits at varying levels of severity3 for
autism spectrum disorder (ASD), attention-deficit/
hyperactivity disorder (ADHD), and learning difficulties.4 A
more recent UK-based twin study5 that used a contempo-
rary analytic approach reported a genetic correlation of 0.70
between ASD and autistic traits. To our knowledge, this
approach has not been applied to other psychiatric pheno-
types, meaning that the degree of genetic correlation
between most psychiatric disorders and related traits has
been largely understudied using twin methods. Few twin
studies have focused on the links between anxiety and
major depressive disorder (MDD) with the traits of these
disorders despite these being 2 of the most common
psychiatric diagnoses.
Molecular genetic methods also allow estimation of
genetic correlations between psychiatric disorders and sub-
clinical traits of these disorders based on additive, common
genome-wide variants. Such studies report strong genetic
correlations across disorders and traits for ADHD and MDD,
with a moderate estimate for ASD.4 This approach requires
large genome-wide data sets, however, which are lacking for
psychiatric traits beyond symptoms of ADHD, MDD, and
ASD.6,7 An alternative approach is to calculate polygenic risk
scores (PRSs) based on discovery genome-wide association
studies (GWASs) of psychiatric disorders; PRSs capture an
individual’s common variant risk for a phenotype.8 A
review4 of preliminary studies reported that psychiatric dis-
order PRSs are associated with corresponding population
traits of ASD, ADHD, obsessive-compulsive disorder (OCD),
and MDD, with null or mixed findings for schizophrenia and
bipolar disorder (BD).
Although some preliminary evidence supports shared
genetic risks across disorders and traits for some psychiatric
phenotypes, evidence is weak, mixed, or entirely lacking for
many phenotypes. We aimed to assess the degree of shared
genetic risks between disorders and traits for multiple
psychiatric disorders. Leveraging data from a unique twin
sample, with comprehensive clinical diagnostic, trait
measurement, and genetic data available, enabled us to
perform twin modeling and molecular genetic methods
in the same sample. We used a novel twin method5 to
estimate the genetic correlation between psychiatric diag-
noses and continuous traits of these disorders. We then cal-
culated PRSs based on recent, large-scale GWASs and
tested their associations with continuous variation in
related phenotypes.
Methods
Participants
Familiesofall twinsborn inSwedenbeginning in1992werecon-
tacted in connectionwith the twins’ ninthbirthday (earlier co-
horts included individuals aged 12years) and invited topartici-
pateintheChildandAdolescentTwinStudyinSweden(CATSS).9
The response ratewas 75%. Follow-upswere conductedwhen
the twinswere 15years of age (response rate, 61%) and 18years
of age (response rate, 59%). Exclusion criteria were brain inju-
ries(n = 207pairs),chromosomalsyndromes(n = 35pairs),death
(n = 29pairs),andmigration(n = 100pairs).Phenotypicdatawere
availablefor13923pairsat9yearsofage(1983monozygoticmale
[MZM], 2641 dizygotic male [DZM], 2108monozygotic female
[MZF],2304dizygoticfemale[DZF],and4887dizygoticopposite-
sex [DZOS]), 5165 pairs at 15 years of age (649MZM, 854 DZM,
831MZF,924DZF, and1907DZOS), and4273pairs at 18yearsof
age (553MZM,693DZM,722MZF,747DZF,and1558DZOS). Zy-
gositywasascertainedusingapanelof48single-nucleotidepoly-
morphisms(SNPs)or5questionsconcerningtwinsimilarity.The
lattermethodwas only used in caseswith a 95%probability of
correct classification. Zygosity was reconfirmed for pairs with
genotypedata.All familiesprovidedwritten informedconsent
beforeparticipation, andall dataweredeidentified. This study
receivedethical approval fromtheKarolinska InstitutetEthical
ReviewBoard.
DNAsamples (fromsaliva)were obtained from theCATSS
participants at study enrollment. A total of 11 551 individuals
with available DNA were genotyped using the Illumina Psy-
chChip. Standard quality control and imputation procedures
were performed in the sample; for details, see the article by
Brikell et al.10 A total of 11 081 samples passed quality control
assessment; MZ twins were then imputed, resulting in 13 576
samples and 6981 993 imputed SNPs that passed all quality
control assessments. After individual-level exclusions (de-
scribed above), 13 412 children (50.2% females) were in-
cluded in genetic analyses.
PhenotypicMeasures
Clinical Diagnoses
The CATSS is linkedwith the Swedish National Patient Regis-
ter (NPR).11 The NPR contains International Statistical Classi-
Key Points
Question Are genetic risks for psychiatric disorders associated
with subclinical population traits of these disorders?
Findings Phenotype data were available for 13 923 twin pairs at
9 years of age, 5165 pairs at 15 years of age, and 4273 pairs at
18 years of age, and genetic data were available for 13 412
individuals. Genetic risk factors for psychiatric disorders were
associated with risk factors for subclinical traits; polygenic risk
scores for psychiatric disorders were also significantly associated
with subclinical traits.
Meaning The findings suggest that psychiatric disorders are
associated with continuously distributed genetic risks throughout
the general population.
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fication of Diseases and Related Health Problems, Tenth Revi-
sion (ICD-10) codes for diagnoses from all visits to specialist
inpatient and outpatient care in Sweden. Inpatient data were
available for January 1, 1987, to December 31, 2014, and out-
patient data for January 1, 2001, to December 31, 2013. Diag-
noses of ASD, ADHD, intellectual disability (ID), tic disorders
(TDs), OCD, anxiety disorders (ADs), and MDD were ex-
tracted.Diagnostic codes and thenumbers of individualswith
eachdiagnosis aregiven inTable 1. At theendof follow-up (De-
cember 31, 2014), the individuals in this study were between
9and22years of age.Data analysiswasperformed fromJanu-
ary 1, 2017, to September 30, 2017.
ContinuousMeasures
Traits of ASD, ADHD, ID, TDs, OCD, ADs, andMDDweremea-
sured using continuous scales at 9 and 12 years of age. Inter-
nalizing problems (related to ADs and MDD) were then mea-
sured at 15 years of age. Traits of OCD, ADs, MDD,mania, and
psychotic-like experiences were assessed at 18 years of age.
Details of these measures and sample sizes are provided in
Table 1, with additional details provided in eTable 1 in
the Supplement.
Analyses
Twin Analyses
We used joint categorical/continuous twin models to esti-
mate the degree of etiologic overlap between continuous
traits and categorical diagnoses. These models assume a
normal distribution of continuous liability underlying psy-
chiatric disorders, whereas questionnaires were treated con-
tinuously. The model partitions variance in each phenotype
into additive genetic (A), nonadditive genetic (D), shared
environmental (C), and nonshared environmental (E, which
encompasses measurement error) components. The correla-
tions among these components are then estimated between
2 phenotypes. The phenotypic correlations were decom-
Table 1. Description of the CATSS Sample andMeasuresa
Phenotype
NPR Diagnosis Study Measures
ICD-10
Diagnostic
Codes
Affected, No. (%)
Description of Measure
No. of Individuals With Data
Twin Analyses
Genetic
Analyses Twin Analyses Genetic Analyses
ASD F84 253 (0.9) 142 (1.1) Ages of 9 and 12 y: parent-rated A-TAC ASD
module (17 items)
27 780 13 396
ADHD F90 824 (3.0) 440 (3.3) Ages of 9 and 12 y: parent-rated A-TAC ADHD
module (19 items)
27 759 13 391
ID F70-F73 166 (0.6) 77 (0.6) Ages of 9 and 12 y: parent-rated A-TAC learning
module (3 items)
27 804 13 400
TDs F95 103 (0.4) 43 (0.3) Ages of 9 and 12 y: parent-rated A-TAC tics module
(3 items)
27 791 13 396
OCD F42 118 (0.4) 67 (0.5) Ages of 9 and 12 y: parent-rated A-TAC
compulsions module (2 items)
27 802 13 400
Age of 18 y: self-rated BOCS (15 items) 5757 3982
ADs F40-F41 474 (1.7) 251 (1.9) Ages of 9 and 12 y: parent-rated SCARED (41
items)
15 589 6806
Age of 15 y: parent-rated SDQ-E (5 items) 7663 5703
Age of 15 y: self-rated SDQ-E (5 items) 8150 5917
Age of 18 y: parent-rated ABCL DSM-IV anxiety
subscale (6 items)
5160 3755
Self-rated SCARED (38 items) 5801 4007
MDD F32-F34 414 (1.5) 222 (1.7) Ages of 9 and 12 y: parent-rated SMFQ (13 items) 15 873 6826
Age of 15 y: parent-rated SDQ-E (5 items); 7663 5703
Age of 15 y: self-rated SDQ-E (5 items); 8150 5917
Age of 18 y: parent-rated ABCL DSM-IV depression
subscale (15 items);
5215 3791
Self-rated CES-D (11 items) 5518 3813
Mania NA NA NA Age of 18 y: parent-rated MDQ (13 items) NA 3808
Age of 18 y: self-rated MDQ (13 items) NA 4128
Psychosis NA NA NA Age of 18 y: parent-rated APSS (7 items) NA 5368
Age of 18 y: self-rated APSS (7 items) NA 5518
Abbreviations: ABCL, Adult Behavior Checklist12; ADs, anxiety disorders; ADHD,
attention-deficit/hyperactivity disorder; APSS, Adolescent Psychotic-Like
Symptom Screener13; ASD, autism spectrum disorder; A-TAC, Autism-Tics,
AD/HD, and Other Comorbidities Inventory14,15; BOCS, Brief Obsessive-
Compulsive Scale16; CATSS, Child and Adolescent Twin Study in Sweden; CES-D,
Center for Epidemiologic Studies Depression Scale17; ICD-10, International
Statistical Classification of Diseases and Related Health Problems, Tenth
Revision; ID, intellectual disability; MDD, major depressive disorder; MDQ,
Mood Disorder Questionnaire18; NA, not applicable; NPR, National Patient
Register; OCD, obsessive-compulsive disorder; SCARED, Screen for Child
Anxiety Related Emotional Disorders19; SDQ-E, Strengths and Difficulties
Questionnaire20; SMFQ, Short Mood and Feelings Questionnaire21; TDs, tic
disorders.
a Diagnoses of bipolar disorder and schizophrenia were not included because of
small numbers of participants with these diagnoses. There were too few items
to divide the SDQ-E subscale into anxiety and depression separately.
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posed into genetic and environmental factors to assess
which factors explain the correlation between psychiatric
diagnoses and traits. On the basis of twin correlations, we
tested ACE or ADE models for each disorder-trait pairing.
We included a sibling interaction term in ADE models
(ADE-s) because these interactions can mimic the effects of
D on the twin correlations.22 The principles of the twin
design are described at length elsewhere.23
The ACE or ADE-s model was compared with a saturated
model of the observed data. If the pattern of twin correla-
tions differed between the continuous trait and the cat-
egorical diagnoses, both models were fitted and the best-
fitting model was chosen on the basis of the lowest Bayesian
Information Criteria value. More parsimonious models were
tested by reducing each model by constraining certain com-
ponents to equal zero and comparing these models to the
ACE or ADE-s model using the likelihood ratio test; if the
model fit did not deteriorate significantly, the reduced
model was favored. Continuous scales were standardized by
sex, whereas the association of sex with the thresholds were
included in the models. Models were fitted in OpenMx.24
Opposite-sex twins were included, but the study was under-
powered to test for sex differences. Obsessive-compulsive
disorder was omitted from the twin analyses because of the
small sample and low heritability.
PRS Analyses
Publicly available GWAS summary statistics for 8 psychiatric
disorders (ie,ASD,ADHD,TDs,OCD,ADs,MDD,BD,andschizo-
phrenia) and 3 continuously distributed psychiatric or cogni-
tive traits (ie, ADHD symptoms, cognitive ability, and depres-
sive symptoms) were used to derive PRSs in the CATSS
individuals.25-34 eTable 2 in the Supplement lists these dis-
covery data sets along with sample sizes. Discovery and tar-
getdatawere independent (detailsofPRScalculationsaregiven
in the eAppendix in the Supplement). In brief, PRSswere cal-
culated in imputed CATSS data for each individual by scoring
the number of effect alleles (weighted by the SNP effect size)
across each discovery set of clumped SNPs in PLINK, version
1.9, for a range of P value thresholds used for SNP selection.
The primary analyses are based on the threshold P < .50. The
PRSswere standardized using z-score transformations; effect
sizes can be interpreted as increase in risk of the outcome per
SD increase in PRS. Principal component analysiswas used to
derive covariates to account forpopulation stratification (eAp-
pendix in the Supplement).
Analyses of PRSs were performed using generalized esti-
mating equations using theRpackage drgee,with robust SEs,
basedon clustering related individuals to account for twins in
the data. The principal components, sex, and age (for mea-
sures thatwere assessed at 9 or 12 years of age)were included
as covariates. First,we tested for associationbetweenPRSs for
eachof the8discoveryGWASsofpsychiatricdisorders and the
correspondingcontinuouslydistributed trait(s). Second, these
analyses were repeated after excluding individuals diag-
nosed with the relevant psychiatric disorder based on avail-
able information on ICD-10 diagnoses to determine whether
effectsweredrivenprimarilyby individualswithclinically rec-
ognized problems. Third, we tested for associations between
PRSs for each of the 3 discovery GWASs of continuously dis-
tributed population traits and the corresponding psychiatric
diagnosis in the target sample. Fourth, all PRS analyses were
repeated using PRSs derived on the basis of different P value
selection thresholds to assess sensitivity. False discovery rate
correctionswereapplied inR (using the fdrmethod in the func-
tion p.adjust) (R Foundation for Statistical Computing) to ac-
count for multiple testing.
Supplemental Analyses
Because there is some evidence of genetic specificity within
ASD and ADHD trait domains,35,36 we reran all twin and PRS
analyses for 3 specific DSM-IV ASD dimensions (social prob-
lems, language impairment, and behavioral inflexibility) and
2DSM-IVADHDdimensions (hyperactivity/impulsivityand in-
attention). These domains were assessed by dividing the Au-
tism-Tics,AD/HD,andOtherComorbidities InventoryASDand
ADHD subscales based on prior work.9
Results
Twin Analyses
Phenotypedatawere available for 13 923 twinpairs (35.1%op-
posite sex and 31.7% same-sex females) at 9 years of age, 5165
pairs (36.9% opposite sex and 34.0% same-sex females) at
15 years of age, and 4273 pairs (36.5%opposite sex and 34.4%
same-sex females) at 18 years of age. Genetic data were avail-
able for 13 412 individuals (50.2% females). Probandwise con-
cordances for each diagnosis, which represent the probabil-
ity of co-twins of probands also receiving a given diagnosis,
are given in eTable 3 in the Supplement. The MZ proband-
wise concordances all exceeded the DZ estimates, indicating
genetic associationswith eachdiagnosis. Phenotypic correla-
tionsbetweendisorders and related traits ranged from0.22 for
MDD to 0.66 for ID (mean estimate, 0.40) (Table 2). The MZ
twin correlationswere higher than theDZ correlationswithin
each disorder and trait and across disorder-trait pairs, sug-
gesting that each phenotype and the covariance betweenwas
associated with genetic factors.
For all traits, AE-s or AE models fit best except for ADs
at 9 and 12 years of age, where there was a small, significant
C estimate (eTable 4 in the Supplement). Variance compo-
nents and etiologic correlations from each model are given
in eTable 5 in the Supplement. All measures and diagnoses
except for the Strengths and Difficulties Questionnaire at 15
years of age and self-reported MDD at 18 years of age were
under strong genetic influence. The genetic and nonshared
environmental correlations are shown in the Figure. Point
estimates of genetic correlation varied: 0.48 for ASD (95%
CI, 0.44-0.53), 0.56 for ADHD (95% CI, 0.53-0.59), 0.69 for
ID (95% CI, 0.64-0.73), 0.61 for TDs (95% CI, 0.51-0.80),
0.46 to 0.57 for ADs (95% CI, 0.34-0.58 and 0.46-0.68), and
0.33 to 0.58 for MDD (95% CI, 0.19-0.47 and 0.52-0.63). For
anxiety and MDD, higher genetic correlations were esti-
mated at 18 years of age. However, most of the CIs around
the genetic correlations overlapped. Shared genetic factors
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explained 60% to 100% (mean estimate, 80.7%) of the phe-
notypic covariance between each trait and diagnosis (eTable
5 in the Supplement).
Analyses of specific ASD and ADHD domains are given in
eTables 6 and 7 in the Supplement. All ASD trait domains dis-
playedmoderatephenotypic (meanestimate,0.41; range,0.43-
0.48) and genetic correlations (mean estimate, 0.46; range,
0.43-0.47) with ASD, whereas both ADHD dimensions dis-
playedmoderatephenotypic (meanestimate,0.49; range,0.45-
0.53) andgenetic (meanestimate, 0.53; range, 0.49-0.57) cor-
relations with ADHD.
PRS Analyses
The PRSs for psychiatric disorders were associated with
related traits for all disorders except BD (Table 3). At 9 years
of age, ASD PRSs were associated with autistic traits (β
[SE] = 0.04 [0.01]), ADHD PRSs were associated with ADHD
traits (β [SE] = 0.27 [0.03]), and TD PRSs were associated
with tic problems (β [SE] = 0.02 [0.004]). The OCD PRSs
were associated with obsessive-compulsive symptoms at 18
years of age (β [SE] = 0.13 [0.05]) but not at 9 and 12 years of
age (β [SE] = 0.002 [0.002]). The AD PRSs were associated
with anxiety traits at 9 years of age (β [SE] = 0.18 [0.08]),
parent-rated internalizing traits at 15 years of age (β
[SE] = 0.07 [0.02]), and self-rated traits at 18 years of age (β
[SE] = 0.40 [0.17]) but not with self-rated internalizing traits
at 15 years of age (β [SE] = 0.06 [0.03]) and parent-rated
symptoms at 18 years of age (β [SE] = 0.04 [0.03]). The MDD
PRSs were associated with all measures of depressive symp-
toms (β [SE] = 0.10 [0.03] at 9 years of age, β [SE] = 0.11
[0.02] at 15 years of age parent-rated, β [SE] = 0.11 [0.03] at
15 years of age self-rated, β [SE] = 0.25 [0.06] at 18 years of
age parent-rated; β [SE] = 0.41 [0.10] at 18 years of age self-
rated). Schizophrenia PRSs were associated with psychotic
traits at 18 years of age (β [SE] = 0.02 [0.01]).
After removing individuals diagnosed with the relevant
psychiatric disorder, the results remained significant forASD,
ADHD,TDs,OCD,ADs, andMDD, although the effect sizes de-
creased (Table 3). All estimates of variance explained were
modest (mean, 0.23%; range, 0.01%-0.84%).
In the analysis of PRSs for quantitative traits associated
withpsychiatricdiagnoses (Table4), PRSs fordepressivesymp-
tomswereassociatedwithMDDdiagnosis (oddsratio [OR], 1.16;
95% CI, 1.02-1.32); PRSs for traits of ADHD (OR, 1.09; 95% CI,
0.98-1.22) and general cognitive ability (OR, 0.97; 95% CI,
0.76-1.23) were not associatedwith related diagnoses (ADHD
and ID, respectively).
Secondary analyses for ASD and ADHD PRSs associated
with specific trait domains are given in eTable 8 in theSupple-
ment. The analyses of these subdomainswere consistentwith
the analyses of total ASD (social: β [SE] = 0.011 [0.006], lan-
guage:β [SE] = 0.011 [0.006], flexibility:β [SE] = 0.022[0.005])
andADHD(hyperactivity/impulsivity: β [SE] = 0.14 [0.015], in-
attention: β [SE] = 0.130 [0.016]) trait scores except that, for
ASD, only the estimate for flexibility remained significant af-
ter excluding individuals with ASD diagnoses.
All analyses were repeated using PRSs derived on the ba-
sis of different P value thresholds for SNP inclusion (eFigure
in the Supplement). The pattern of results was consistent in
these sensitivity analyses, but 1 result (ie, ADs at 18 years of
age) was not statistically significant after false discovery
rate correction.
Discussion
Using a unique, large, genotyped twin sample, we tested for
geneticassociationsbetweenclinicalpsychiatricdiagnosesand
related traits. All disorders analyzed using novel twinmodels
(ASD,ADHD,TDs, ID,ADs, andMDD) showedmodest to strong
genetic correlations with related traits. Squaring these corre-
lations gives the proportion of genetic variance shared be-
tween 2 traits; thus, our findings suggest that at least a mod-
est proportion of genetic factors associated with clinical
psychiatric disorders are associated with continuous varia-
Figure. Genetic and Nonshared Environmental Correlations
Between Psychiatric Diagnoses and Traits
From the Best-Fitting TwinModels
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ABCL, Adult Behavior Checklist; ADHD, attention-deficit/hyperactivity disorder;
ASD, autism spectrum disorder; A-TAC: Autism-Tics, AD/HD, and Other
Comorbidities Inventory; CES-D, Center for Epidemiologic Studies Depression
Scale; MDD, major depressive disorder; SCARED, Screen for Child Anxiety
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tion in milder traits of these disorders. This finding repli-
cated the results of an earlier study5 of ASD and extended the
method tomanyother disorders. Commonvariant PRS analy-
ses supported these results, revealing anassociationof shared
risks between ASD, ADHD, TDs, OCD, ADs, MDD, and schizo-
phreniaandrelated traits, evenafterexcluding individualswho
had receivedadiagnosis,wherepossible.These converging re-
sults using 2 contemporarymethods revealed thatmany psy-
chiatric disorders may share genetic risks with continuous
symptom dimensions in the population.
Our study went beyond traditional twin studies by di-
rectly estimating the genetic correlation between psychiatric
Table 4. Association of Continuous Trait PRSsWith Related Binary Outcomes
Discovery PRS Outcome (Diagnosis) No. of Individuals OR (95% CI) P Value R2
ADHD traits ICD-10 (ADHD) 13 412 1.09 (0.98-1.22) .13 9.9 × 10−4
General cognition ICD-10 (ID) 13 412 0.97 (0.76-1.23) .78 9.6 × 10−5
Depressive traits ICD-10 (MDD) 13 412 1.16 (1.02-1.32) .04a 2.3 × 10−3
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ICD-10,
International Statistical Classification of Diseases and Related Health Problems,
Tenth Revision; ID, intellectual disability; MDD, major depressive disorder; OR,
odds ratio; PRS, polygenic risk score.
a False discovery rate P < .05.
Table 3. Association of PRSsWith Related Continuous Outcomes
Discovery PRS, Outcome
(Age, y)
Full Sample Excluding Those With ICD-10 Diagnoses
β (SE) P Value R2 β (SE) P Value R2
ASD
A-TAC ASD (9 and 12) 0.043 (0.014) 5.4 × 10−3a 9.5 × 10−4 0.036 (0.013) 6.7 × 10−3a 8.2 × 10−4
ADHD
A-TAC ADHD (9 and 12) 0.268 (0.029) 5.9 × 10−19b 8.4 × 10−3 0.205 (0.027) 2.2 × 10−13b 6.2 × 10−3
TDs
A-TAC tics (9 and 12) 0.015 (0.004) 6.6 × 10−4b 1.2 × 10−3 0.016 (0.004) 5.3 × 10−4b 1.3 × 10−3
OCD
A-TAC OC traits (9 and 12) 0.002 (0.002) 0.333 1.2 × 10−4 0.002 (0.002) 0.262 1.4 × 10−4
BOCS (18) 0.126 (0.047) 0.014c 2.3 × 10−3 0.132 (0.046) 6.7 × 10−3a 2.6 × 10−3
ADs
SCARED (9) 0.180 (0.078) 0.033c 9.1 × 10−4 0.186 (0.078) 0.023c 1.0 × 10−3
SDQ-E parent-rated (15) 0.069 (0.023) 5.4 × 10−3a 1.9 × 10−3 0.054 (0.022) 0.018c 1.3 × 10−3
SDQ-E self-rated (15) 0.061 (0.030) 0.060 7.3 × 10−4 0.055 (0.030) 0.077 6.1 × 10−4
ABCL anxiety (18) 0.043 (0.030) 0.186 6.6 × 10−4 0.032 (0.029) 0.262 4.2 × 10−4
SCARED (18) 0.404 (0.171) 0.031c 1.5 × 10−3 0.344 (0.166) 0.047c 1.2 × 10−3
MDD
SMFQ (9) 0.095 (0.028) 2.1 × 10−3a 2.0 × 10−3 0.095 (0.028) 1.7 × 10−3a 2.0 × 10−3
SDQ-E parent-rated (15) 0.105 (0.023) 5.3 × 10−5b 4.4 × 10−3 0.079 (0.022) 1.3 × 10−3a 2.7 × 10−3
SDQ-E self-rated (15) 0.105 (0.030) 1.3 × 10−3a 2.1 × 10−3 0.087 (0.029) 6.5 × 10−3a 1.5 × 10−3
ABCL depression (18) 0.249 (0.055) 5.3 × 10−5b 7.3 × 10−3 0.186 (0.049) 6.3 × 10−4b 5.1 × 10−3
CES-D (18) 0.408 (0.100) 2.3 × 10−4b 4.8 × 10−3 0.343 (0.097) 1.3 × 10−3a 3.6 × 10−3
BD
MDQ parent-rated (18) -0.045 (0.061) 0.478 2.3 × 10−4 NAd NAd NAd
MDQ self-rated (18) -0.054 (0.058) 0.388 2.4 × 10−4 NAd NAd NAd
Schizophrenia
APSS parent-rated (18) 0.024 (0.010) 0.031c 1.5 × 10−3 NAd NAd NAd
APSS self-rated (18) 0.062 (0.021) 8.4 × 10−3a 1.7 × 10−3 NAd NAd NAd
Abbreviations: ABCL, Adult Behavior Checklist; ADs, anxiety disorders; ADHD,
attention-deficit/hyperactivity disorder; APSS, Adolescent Psychotic-Like
Symptom Screener; ASD, autism spectrum disorder; A-TAC, Autism-Tics, AD/HD,
and Other Comorbidities Inventory; BD, bipolar disorder; BOCS, Brief
Obsessive-Compulsive Scale; CES-D, Center for Epidemiologic Studies
Depression Scale; ICD-10, International Statistical Classification of Diseases and
Related Health Problems, Tenth Revision; MDD, major depressive disorder;
MDQ, Mood Disorder Questionnaire; NA, not applicable; OCD,
obsessive-compulsive disorder; PRS, polygenic risk score; SCARED, Screen for
Child Anxiety Related Emotional Disorders; SDQ-E, Strengths and Difficulties
Questionnaire, emotional problems subscale; SMFQ, Short Mood and Feelings
Questionnaire; TDs, tic disorders.
a False discovery rate P < .01.
b False discovery rate P < .001.
c False discovery rate P < .05.
d Sample too young to exclude individuals diagnosed with BD or schizophrenia.
The PRSs were derived using common variants with P < .50 in the discovery
data.
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disorders and continuous traits;we also assessed the associa-
tion betweendisorder PRSs and continuous traits in the same
sample.Dichotomousdefinitionsofpsychiatric disordersmay
not be optimal for all studies of these phenotypes. Our re-
sults indicate thatmovingbeyonddichotomousdefinitionsof
psychiatric disorders to joint analyses of disorders and traits
may increase statistical power and yield insights into the bi-
ology of these traits. The value of such an approachwas dem-
onstrated by a recent ADHDGWAS.26 Studies of traits in com-
munity-based samplesmay also bemore representative than
clinical sampleswhile generating results that, to adegree, gen-
eralize to clinical populations.
However, genetic correlations in the twin analyses were
less than 1. Associations betweenPRSs and traits had small ef-
fect sizes (which is typical of PRS studies). Thus, only a pro-
portionofgenetic riskswere sharedacrossdisorders and traits.
Although twin methods capture all sources of inherited ge-
netic risk, PRSs are limited to additive common effects. Rare
genetic variantsmayhaveamoredeleterious effect than com-
monvariants;however, several studieshavedemonstratedge-
netic overlap from rare variants across disorders and continu-
ous measures of ASD37 and ID.38 Correlations between
environmental factors associated with psychiatric disorders
and traits were also lower than the genetic correlations, sug-
gesting that environmental factors associated with psychiat-
ric disordersmaybemoreunique topsychiatricdisorders than
genetic factors. Future work identifying risk factors that are
not shared between psychiatric traits and disordersmay thus
help elucidatewhy some individuals presentwithmild traits,
whereas others manifest clinically severe problems.
Strengths and Limitations
A unique strength of our study was that we were able to per-
form both twin and molecular genetic analyses in 1 cohort.
Linkage with nationwide patient records enabled us to focus
onclinicaldiagnosesofpsychiatricdisordersasopposedtoper-
centile-based cutoffs or screening diagnoses. This study de-
sign allowed the exclusionof individuals diagnosedwithpsy-
chiatric disorders from PRS analyses, thus ruling out the
possibility that observed effects were driven by individuals
with clinically recognized problems. Assessments from
multiple ages and raters led to a wealth of information on
psychiatric phenotypes.
Nonetheless, the sample was young. Althoughmany dis-
orders develop during childhood and adolescence, disorders
suchasschizophrenia,BD,andseveredepressionbecomemore
commonwith age. Because fewof theparticipantshadpassed
through the periods of high risk for these disorders, we could
not perform twin analyses of schizophrenia or BD or exclude
those individuals from PRS analyses. Studies of older indi-
viduals are thus needed as a next step. In addition, the NPR
covers specialist care; thus, diagnoses ascribed through pri-
mary care were likely missed.
Specific limitations of the genetic analyses include mod-
est sample sizes andassociated lowpowerof several of thedis-
covery GWAS analyses used to derive PRSs; for certain phe-
notypes, these limitationsmay have led to less robust results
(eg, for ADs and BD). Nonrandom attrition, previously re-
ported to affect genetic studies,39mayhavedecreased theob-
served effect sizes, particularly at later ages. In addition, the
estimates of variance explained were low although typical of
PRS analyses (eg, PRSs explain only 5.5% of the variance in
ADHD clinical case status26) because PRSs capture only the
most strongly associated common variants and rely on dis-
covery GWAS power to accurately estimate SNP effects. Al-
though the PRS results showed the presence of associations
between genetic risk for disorders and traits consistent with
the twin analyses, the degree to which common genetic risks
are shared is unclear from our study. Future studies that use
larger GWAS data sets and other methods are needed to esti-
mate genetic correlations frommolecular genetic data.
We did not have the statistical power to divide the cases
by severity or diagnostic subtype. Thus, we cannot conclude
thatall levelsofdisorderseveritysharegenetic riskswithmilder
traits. This topicwill be an important focus in future research
because there is some evidence that severe ID is genetically
independent from cognitive abilities and milder ID.40 In ad-
dition, all the continuousmeasuresused in this studywerede-
signed to assess potentially problematic behaviors. As such,
we cannot extrapolate our results to the very lowpositive end
of each trait distribution. Studies that use measures that are
sensitive to lower scores are needed.41
Conclusions
Although our results do not rule out the possibility that some
genetic factors are not shared between psychiatric disorders
and milder traits of these disorders, they suggest that a pro-
portion of genetic risks associated with psychiatric disorders
are also associated with milder traits of these disorders. Fu-
ture studies are needed to replicate our findings in older in-
dividuals and to test whether more severe forms of psychiat-
ric disorders also share genetic risks with milder traits.
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